- Home
- WIT vs BNTX Comparison
WIT vs BNTX Comparison
Compare WIT & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WIT | BNTX |
|---|---|---|
| Founded | 1945 | 2008 |
| Country | India | Germany |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.4B | 24.2B |
| IPO Year | 2000 | 2019 |
Fundamental Metrics
Financial Performance| Metric | WIT | BNTX |
|---|---|---|
| Price | $1.94 | $89.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $133.46 |
| AVG Volume (30 Days) | ★ 11.1M | 855.0K |
| Earning Date | 04-16-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.42% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.20 | N/A |
| Revenue Next Year | $4.98 | $3.37 |
| P/E Ratio | $16.59 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.80 | $79.81 |
| 52 Week High | $3.13 | $124.00 |
Technical Indicators
Market Signals| Indicator | WIT | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 40.56 | 34.66 |
| Support Level | N/A | $84.78 |
| Resistance Level | $2.88 | $112.44 |
| Average True Range (ATR) | 0.05 | 3.11 |
| MACD | -0.00 | -1.20 |
| Stochastic Oscillator | 52.00 | 7.03 |
Price Performance
Historical ComparisonAbout WIT Wipro Limited
Wipro is a multinational IT services provider based in Bengaluru, India. The company pivoted into the IT space in the 1980s and grew into one of the largest Indian IT consulting companies during the dot-com boom. Nowadays, Wipro leverages its offshore outsourcing model to derive a significant portion of its revenue from North America and Europe.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.